Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

Hiroyuki Fujiwara, Harushige Yokota, Bradley Monk, Isabelle Treilleux, Mojgan Devouassoux-Shisheboran, Alison Davis, Jae Weon Kim, Sven Mahner, Michael Stany, Sandro Pignata, Isabelle Ray-Coquard, Keiichi Fujiwara

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

Original languageEnglish
Pages (from-to)S96-S101
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number9
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Adenocarcinoma
Cervix Uteri
Squamous Cell Carcinoma
Neoplasms
Epidemiology
Clinical Trials
Guidelines
Pathology
Carcinoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fujiwara, H., Yokota, H., Monk, B., Treilleux, I., Devouassoux-Shisheboran, M., Davis, A., ... Fujiwara, K. (2014). Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. International Journal of Gynecological Cancer, 24(9), S96-S101. https://doi.org/10.1097/IGC.0000000000000263

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. / Fujiwara, Hiroyuki; Yokota, Harushige; Monk, Bradley; Treilleux, Isabelle; Devouassoux-Shisheboran, Mojgan; Davis, Alison; Kim, Jae Weon; Mahner, Sven; Stany, Michael; Pignata, Sandro; Ray-Coquard, Isabelle; Fujiwara, Keiichi.

In: International Journal of Gynecological Cancer, Vol. 24, No. 9, 01.11.2014, p. S96-S101.

Research output: Contribution to journalArticle

Fujiwara, H, Yokota, H, Monk, B, Treilleux, I, Devouassoux-Shisheboran, M, Davis, A, Kim, JW, Mahner, S, Stany, M, Pignata, S, Ray-Coquard, I & Fujiwara, K 2014, 'Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma', International Journal of Gynecological Cancer, vol. 24, no. 9, pp. S96-S101. https://doi.org/10.1097/IGC.0000000000000263
Fujiwara H, Yokota H, Monk B, Treilleux I, Devouassoux-Shisheboran M, Davis A et al. Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. International Journal of Gynecological Cancer. 2014 Nov 1;24(9):S96-S101. https://doi.org/10.1097/IGC.0000000000000263
Fujiwara, Hiroyuki ; Yokota, Harushige ; Monk, Bradley ; Treilleux, Isabelle ; Devouassoux-Shisheboran, Mojgan ; Davis, Alison ; Kim, Jae Weon ; Mahner, Sven ; Stany, Michael ; Pignata, Sandro ; Ray-Coquard, Isabelle ; Fujiwara, Keiichi. / Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma. In: International Journal of Gynecological Cancer. 2014 ; Vol. 24, No. 9. pp. S96-S101.
@article{cdc5700d4fdb4080bd80e84c74142158,
title = "Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma",
abstract = "Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25{\%} of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.",
author = "Hiroyuki Fujiwara and Harushige Yokota and Bradley Monk and Isabelle Treilleux and Mojgan Devouassoux-Shisheboran and Alison Davis and Kim, {Jae Weon} and Sven Mahner and Michael Stany and Sandro Pignata and Isabelle Ray-Coquard and Keiichi Fujiwara",
year = "2014",
month = "11",
day = "1",
doi = "10.1097/IGC.0000000000000263",
language = "English",
volume = "24",
pages = "S96--S101",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

AU - Fujiwara, Hiroyuki

AU - Yokota, Harushige

AU - Monk, Bradley

AU - Treilleux, Isabelle

AU - Devouassoux-Shisheboran, Mojgan

AU - Davis, Alison

AU - Kim, Jae Weon

AU - Mahner, Sven

AU - Stany, Michael

AU - Pignata, Sandro

AU - Ray-Coquard, Isabelle

AU - Fujiwara, Keiichi

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

AB - Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

UR - http://www.scopus.com/inward/record.url?scp=84931294375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931294375&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000263

DO - 10.1097/IGC.0000000000000263

M3 - Article

VL - 24

SP - S96-S101

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 9

ER -